menu search

Mydecine innovations announces appointment of dr victoria hale to the company's board of directors

Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) has announced the appointment of Dr Victoria Hale to the company's board of directors.  The comp...

February 3, 2022, 8:40 am

Mydecine innovations announces appointment of dr victoria hale to the company's board of directors

Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) has announced the appointment of Dr Victoria Hale to the company's board of directors.  The comp...

February 3, 2022, 8:40 am

Mydecine innovations announces appointment of dr victoria hale to the company's board of directors

Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) has announced the appointment of Dr Victoria Hale to the company's board of directors.  The comp...

February 3, 2022, 8:40 am

Graybug to participate in three upcoming medical and investor conferences

BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmace...

February 3, 2022, 7:30 am

Graybug to participate in three upcoming medical and investor conferences

BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmace...

February 3, 2022, 7:30 am

Graybug to participate in three upcoming medical and investor conferences

BALTIMORE, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (Nasdaq: GRAY), a clinical-stage biopharmace...

February 3, 2022, 7:30 am

Aurinia pharmaceuticals to present at the 11th annual leerink global healthcare conference

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...

February 3, 2022, 7:05 am

Here's what to like about johnson & johnson's q4 update

The pharmaceutical segment continues to be J&J's biggest growth driver....

February 3, 2022, 7:05 am

Aurinia pharmaceuticals to present at the 11th annual leerink global healthcare conference

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...

February 3, 2022, 7:05 am

Here's what to like about johnson & johnson's q4 update

The pharmaceutical segment continues to be J&J's biggest growth driver....

February 3, 2022, 7:05 am

Aurinia pharmaceuticals to present at the 11th annual leerink global healthcare conference

VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia pharmaceuticals Inc. (NASDAQ: AUPH) (the “Compan...

February 3, 2022, 7:05 am

Here's what to like about johnson & johnson's q4 update

The pharmaceutical segment continues to be J&J's biggest growth driver....

February 3, 2022, 7:05 am

West to host fourth-quarter and full-year 2021 conference call

EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global lead...

February 3, 2022, 6:00 am

West to host fourth-quarter and full-year 2021 conference call

EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global lead...

February 3, 2022, 6:00 am

West to host fourth-quarter and full-year 2021 conference call

EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West pharmaceutical Services, Inc. (NYSE: WST), a global lead...

February 3, 2022, 6:00 am

Covid becoming endemic will require need for testing in future, roche ceo says

Roche CEO Severin Schwan discusses the Swiss pharmaceutical's full-year 2021 earnings and the impact of...

February 3, 2022, 4:13 am

Covid becoming endemic will require need for testing in future, roche ceo says

Roche CEO Severin Schwan discusses the Swiss pharmaceutical's full-year 2021 earnings and the impact of...

February 3, 2022, 4:13 am

Covid becoming endemic will require need for testing in future, roche ceo says

Roche CEO Severin Schwan discusses the Swiss pharmaceutical's full-year 2021 earnings and the impact of...

February 3, 2022, 4:13 am

Arrowhead pharmaceuticals, inc. (arwr) ceo dr. christopher anzalone on q1 2022 results - earnings call transcript

Arrowhead pharmaceuticals, Inc. (ARWR) CEO Dr. Christopher Anzalone on Q1 2022 Results - Earnings Call ...

February 2, 2022, 9:40 pm

Arrowhead pharmaceuticals, inc. (arwr) ceo dr. christopher anzalone on q1 2022 results - earnings call transcript

Arrowhead pharmaceuticals, Inc. (ARWR) CEO Dr. Christopher Anzalone on Q1 2022 Results - Earnings Call ...

February 2, 2022, 9:40 pm


Search within

Pages Search Results: